Cargando…

Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review

HIV-associated neurocognitive disorders (HANDs) still persist despite improved life expectancy, reduced viral loads, and decreased infection severity. The number of patients affected by HANDs ranges from (30 to 50) % of HIV-infected individuals. The pathological mechanisms contributing to HANDs and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borrajo, Ana, Pérez-Rodríguez, Daniel, Fernández-Pereira, Carlos, Prieto-González, José María, Agís-Balboa, Roberto Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531836/ https://www.ncbi.nlm.nih.gov/pubmed/37762667 http://dx.doi.org/10.3390/ijms241814364

Ejemplares similares

Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
por: Borrajo López, Ana, et al.
Publicado: (2021)

Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis
por: Borrajo, A., et al.
Publicado: (2020)

MyBrain-Seq: A Pipeline for MiRNA-Seq Data Analysis in Neuropsychiatric Disorders
por: Pérez-Rodríguez, Daniel, et al.
Publicado: (2023)

Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders
por: Delgado-Morales, Raúl, et al.
Publicado: (2017)

Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder
por: Fernández-Pereira, Carlos, et al.
Publicado: (2023)

Therapeutic approaches to age-associated neurocognitive disorders
por: O'Hara, Ruth, et al.
Publicado: (2001)

HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities
por: Lindl, Kathryn A., et al.
Publicado: (2010)

Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease
por: Ortolano, Saida, et al.
Publicado: (2014)

Neuroimaging of HIV-associated neurocognitive disorders
por: Haziot, Michel Elyas Jung, et al.
Publicado: (2015)

HIV Associated Neurocognitive Disorders
por: Zhou, Li, et al.
Publicado: (2013)

HIV-associated neurocognitive disorders
por: Sanmarti, Montserrat, et al.
Publicado: (2014)

Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders
por: Merali, Salim, et al.
Publicado: (2014)

Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients
por: Fernández-Pereira, Carlos, et al.
Publicado: (2022)

Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
por: McLaurin, Kristen A., et al.
Publicado: (2019)

Data-Driven Phenotyping of Alzheimer’s Disease under Epigenetic Conditions Using Partial Volume Correction of PET Studies and Manifold Learning
por: Campanioni, Silvia, et al.
Publicado: (2023)

MiRNA Differences Related to Treatment-Resistant Schizophrenia
por: Pérez-Rodríguez, Daniel, et al.
Publicado: (2023)

Microbial Therapeutics in Neurocognitive and Psychiatric Disorders
por: Alagiakrishnan, Kannayiram, et al.
Publicado: (2021)

Targeting neuroinflammation as a preventive and therapeutic approach for perioperative neurocognitive disorders
por: Cheng, Chun, et al.
Publicado: (2022)

Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
por: Omeragic, Amila, et al.
Publicado: (2020)

Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis
por: Jaeger, Laura B., et al.
Publicado: (2012)

The role of dopamine receptors in lymphocytes and their changes in schizophrenia
por: Penedo, M.A., et al.
Publicado: (2021)

Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder
por: Davies, Nicholas W.S., et al.
Publicado: (2010)

Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders
por: Woods, Steven Paul, et al.
Publicado: (2009)

Adjuvant therapies for HIV-associated neurocognitive disorders
por: McGuire, Jennifer L, et al.
Publicado: (2014)

Metabolic Reprogramming in HIV-Associated Neurocognitive Disorders
por: Allen, Charles N. S., et al.
Publicado: (2022)

An Integrative Approach to the Current Treatment of HIV-Associated Neurocognitive Disorders and the Implementation of Leukemia Inhibitor Factor as a Mediator of Neurocognitive Preservation
por: De Freitas-Suarez, Andrés, et al.
Publicado: (2023)

Determining the Neurocognitive Status and the Functional Ability of Patients to Screen for HIV-Associated Neurocognitive Disorder (HAND)
por: Agarwal, Ritika, et al.
Publicado: (2020)

The role of tau protein in HIV-associated neurocognitive disorders
por: Brown, Lecia AM, et al.
Publicado: (2014)

HIV-Associated Neurocognitive Disorders: A Global Perspective
por: Saloner, Rowan, et al.
Publicado: (2017)

The role of oxidative stress in HIV-associated neurocognitive disorders
por: Buckley, Sarah, et al.
Publicado: (2021)

Transcriptomic and Genetic Profiling of HIV-Associated Neurocognitive Disorders
por: Ojeda-Juárez, Daniel, et al.
Publicado: (2021)

Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders
por: Irollo, Elena, et al.
Publicado: (2021)

Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)
por: Kolson, Dennis L.
Publicado: (2022)

The role of CCR5 in HIV-associated neurocognitive disorders
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2022)

Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control
por: Mouchati, Christian, et al.
Publicado: (2022)

HIV and Neurocognitive Dysfunction
por: Spudich, Serena
Publicado: (2013)

Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
por: Pendyala, Gurudutt, et al.
Publicado: (2010)

Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?
por: Torti, Carlo, et al.
Publicado: (2011)

Host Genetic Factors Predisposing to HIV-Associated Neurocognitive Disorder
por: Kallianpur, Asha R., et al.
Publicado: (2014)

Targeting the Glutamatergic System for the Treatment of HIV-Associated Neurocognitive Disorders
por: Potter, Michelle C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1eu3hjnitnk8p6c7mssptiajhd